BeOne Medicines Ltd. American Depositary Shares

Amgen's Board of Directors declared a $2.52 per share dividend for Q1 2026, to be paid on March 6, 2026, to stockholders of record as of February 13, 2026.

Zymeworks Inc. will participate in two upcoming healthcare investor conferences in Miami, including one-on-one meetings and fireside chats, highlighting their biotechnology portfolio and licensed healthcare assets.

Summit Therapeutics' lung cancer drug ivonescimab showed statistically significant improvement in progression-free survival in a phase III trial, outperforming the current standard of care. This positive trial result has sent the company's stock price soaring.